ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 906 participants.
Also called NCT02609698
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 906 participants
- Registry
-
NCT02609698
-
- Other papers using this trial's data
- Efficacy and Safety of 3 Versus 6 Months of Dual-Antiplatelet Therapy in Patients Implanted With a Coroflex ISAR Stents: A Prospective, Multicenter, Randomized Clinical Trial
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT02609698. Randomized; no masking; primary purpose treatment. Start 2015-08 (registry gives no type); primary completion 2018-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- ISAR-DAPT (A Comparative Evaluation of Efficacy and Safety in the 3-Months DAPT Group vs. the 6-Months DAPT Group of Patients Treated With the Coroflex ISAR Stent; A Prospective, Multicenter, Randomized, Open-Label Clinical Trial)
- Condition
- Stable Angina, Unstable Angina, Silent Coronary Ischemia, Coronary Artery Disease
- Intervention (Device)
- Coroflex ISAR
- Intervention (Drug)
- 3 months DAPT
- Intervention (Drug)
- 6 months DAPT
- Lead sponsor
- Ajou University School of Medicine
- Collaborator
- B. Braun Korea Co., Ltd.
Record details
- Record id
cardio:ct-nct02609698- Content hash
2cfc4e0f6c2e2e8a70a83a68df51905b1c18c6bb470de6576aa192addabfcd2f